HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Lautenberg Unveils TSCA Reform Bill, Putting Safety Burden-Of-Proof On Industry

This article was originally published in The Rose Sheet

Executive Summary

Sen. Frank R. Lautenberg, D-N.J., introduced legislation April 14 updating the 35-year-old Toxic Substances Control Act to set the responsibility for chemical safety substantiation squarely on manufacturers’ shoulders.

You may also be interested in...

Lautenberg Plans TSCA Update Bill For 113th Congress

Introducing a bill to modernize the 36-year-old Toxic Substances Control Act is a priority for Sen. Frank Lautenberg, D-N.J., in the 113th Congress.

In Brief

Senator Frank Lautenberg’s TSCA reform bill, the Safe Chemicals Act, advances through the Senate Environmental and Public Works Committee. More news in brief.

L'Oreal/EPA Partnership Could Expand Non-Animal Test Strategies

L’Oreal and the U.S. EPA are collaborating to test the usefulness of the agency’s chemical-screening platform in predicting the toxicity of cosmetic substances – particularly vis-a-vis sensitive endpoints for which alternative tests currently do not exist – in advance of an EU ban on cosmetic products tested on animals.

Related Content




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts